JPMorgan Chase & Co’s Milestone Pharmaceuticals MIST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-3,266
| Closed | -$2.61K | – | 6444 |
|
2025
Q1 | $2.61K | Buy |
3,266
+2,366
| +263% | +$1.89K | ﹤0.01% | 5639 |
|
2024
Q4 | $2.12K | Buy |
+900
| New | +$2.12K | ﹤0.01% | 5581 |
|
2024
Q1 | – | Sell |
-10,662
| Closed | -$17.8K | – | 6566 |
|
2023
Q4 | $17.8K | Sell |
10,662
-233,694
| -96% | -$390K | ﹤0.01% | 5268 |
|
2023
Q3 | $758K | Sell |
244,356
-2,807
| -1% | -$8.7K | ﹤0.01% | 3552 |
|
2023
Q2 | $704K | Sell |
247,163
-128,891
| -34% | -$367K | ﹤0.01% | 3607 |
|
2023
Q1 | $1.48M | Buy |
376,054
+46,330
| +14% | +$183K | ﹤0.01% | 3214 |
|
2022
Q4 | $1.31M | Buy |
329,724
+276,049
| +514% | +$1.09M | ﹤0.01% | 3222 |
|
2022
Q3 | $493K | Buy |
53,675
+50,136
| +1,417% | +$460K | ﹤0.01% | 3759 |
|
2022
Q2 | $21K | Sell |
3,539
-10,041
| -74% | -$59.6K | ﹤0.01% | 5055 |
|
2022
Q1 | $87K | Buy |
13,580
+6,606
| +95% | +$42.3K | ﹤0.01% | 4806 |
|
2021
Q4 | $46K | Buy |
+6,974
| New | +$46K | ﹤0.01% | 5108 |
|
2020
Q4 | – | Sell |
-1,700
| Closed | -$13K | – | 5009 |
|
2020
Q3 | $13K | Buy |
+1,700
| New | +$13K | ﹤0.01% | 4561 |
|